-
1
-
-
84862681805
-
-
Holick M.F. ed. Vitamin D: Physiology, molecular biology, and clinical applications, 2nd ed. New York: Human Press
-
3 on intestinal calcium absorption and renal calcium transport. In:, Holick MF, ed. Vitamin D: Physiology, molecular biology, and clinical applications, 2nd ed. New York: Human Press; 2010, pp 175-87.
-
(2010)
3 on Intestinal Calcium Absorption and Renal Calcium Transport.
, pp. 175-187
-
-
Ajibade, D.1
Benn, B.S.2
Christakos, S.3
-
2
-
-
80053213704
-
-
The parathyroids: basic and clinical concepts. San Diego, CA: Academic Press
-
Bilezikian JP, Marcus R, Levine MA., The molecular genetics of hypoparathyroidism. In: The parathyroids: basic and clinical concepts. San Diego, CA: Academic Press; 2001, pp 779-90.
-
(2001)
The Molecular Genetics of Hypoparathyroidism.
, pp. 779-790
-
-
Bilezikian, J.P.1
Marcus, R.2
Levine, M.A.3
-
3
-
-
47949092540
-
Clinical practice. Hypoparathyroidism
-
July
-
Shoback D,. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008 July; 359: 391-403.
-
(2008)
N Engl J Med.
, vol.359
, pp. 391-403
-
-
Shoback, D.1
-
4
-
-
80053191036
-
-
Autoimmune hypoparathyroidism: the parathyroid glands, 2nd ed. San Diego, CA: Academic Press
-
Bilezikian JP, Marcus R, Levine MA., Autoimmune hypoparathyroidism: the parathyroid glands, 2nd ed. San Diego, CA: Academic Press; 2001, pp 791-806.
-
(2001)
, pp. 791-806
-
-
Bilezikian, J.P.1
Marcus, R.2
Levine, M.A.3
-
5
-
-
51649119637
-
Hypoparathyroidism: Is it time for replacement therapy
-
Sept
-
Horwitz MJ, Stewart AF,. Hypoparathyroidism: is it time for replacement therapy ? J Clin Endocrinol Metab. 2008 Sept; 93: 3307-9.
-
(2008)
J Clin Endocrinol Metab.
, vol.93
, pp. 3307-3309
-
-
Horwitz, M.J.1
Stewart, A.F.2
-
6
-
-
0036181966
-
Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D
-
Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B,. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol. 2002 Feb; 146: 215-22. (Pubitemid 34162914)
-
(2002)
European Journal of Endocrinology
, vol.146
, Issue.2
, pp. 215-222
-
-
Arlt, W.1
Fremerey, C.2
Callies, F.3
Reincke, M.4
Schneider, P.5
Timmermann, W.6
Allolio, B.7
-
7
-
-
0032753368
-
Psychiatric aspects of parathyroid disease
-
Velasco PJ, Manshadi M, Breen K, Lippmann S,. Psychiatric aspects of parathyroid disease. Psychosomatics. 1999 Nov; 40: 486-90. (Pubitemid 29532012)
-
(1999)
Psychosomatics
, vol.40
, Issue.6
, pp. 486-490
-
-
Velasco, P.J.1
Manshadi, M.2
Breen, K.3
Lippmann, S.4
-
8
-
-
0029798867
-
Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism: Results of a short-term randomized crossover trial
-
DOI 10.1001/jama.276.8.631
-
Winer KK, Yanovski JA, Cutler GB Jr., Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA. 1996 Aug; 276: 631-6. (Pubitemid 26278069)
-
(1996)
Journal of the American Medical Association
, vol.276
, Issue.8
, pp. 631-636
-
-
Winer, K.K.1
Yanovski, J.A.2
Cutler Jr., G.B.3
-
9
-
-
0031773242
-
A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism
-
DOI 10.1210/jc.83.10.3480
-
Winer KK, Yanovski JA, Sarani B, Cutler GB Jr., A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab. 1998 Oct; 83: 3480-6. (Pubitemid 28500875)
-
(1998)
Journal of Clinical Endocrinology and Metabolism
, vol.83
, Issue.10
, pp. 3480-3486
-
-
Winer, K.K.1
Yanovski, J.A.2
Sarani, B.3
Cutler Jr., G.B.4
-
10
-
-
0141564588
-
Long-term treatment of hypoparathyroidism: A randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium
-
DOI 10.1210/jc.2002-021736
-
Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr., Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab. 2003 Sept; 88: 4214-20. (Pubitemid 37153722)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.9
, pp. 4214-4220
-
-
Winer, K.K.1
Ko, C.W.2
Reynolds, J.C.3
Dowdy, K.4
Keil, M.5
Peterson, D.6
Gerber, L.H.7
McGarvey, C.8
Cutler Jr., G.B.9
-
11
-
-
51649100312
-
Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism
-
Sept
-
Winer KK, Sinaii N, Peterson D, Sainz B Jr., Cutler GB Jr., Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab. 2008 Sept; 93: 3389-95.
-
(2008)
J Clin Endocrinol Metab.
, vol.93
, pp. 3389-3395
-
-
Winer, K.K.1
Sinaii, N.2
Peterson, D.3
Sainz, Jr.B.4
Cutler, Jr.G.B.5
-
12
-
-
77954468040
-
Long-term treatment of 12 children with chronic hypoparathyroidism: A randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium
-
Jun
-
Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr., Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J Clin Endocrinol Metab. 2010 Jun; 95: 2680-8.
-
(2010)
J Clin Endocrinol Metab.
, vol.95
, pp. 2680-2688
-
-
Winer, K.K.1
Sinaii, N.2
Reynolds, J.3
Peterson, D.4
Dowdy, K.5
Cutler, Jr.G.B.6
-
13
-
-
78149409817
-
Therapy of hypoparathyroidism with intact parathyroid hormone
-
Nov
-
Rubin MR, Sliney J Jr., McMahon DJ, Silverberg SJ, Bilezikian JP,. Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int. 2010 Nov; 21: 1927-34.
-
(2010)
Osteoporos Int.
, vol.21
, pp. 1927-1934
-
-
Rubin, M.R.1
Sliney, Jr.J.2
McMahon, D.J.3
Silverberg, S.J.4
Bilezikian, J.P.5
-
14
-
-
80053178425
-
-
Thomsen J. Vestergaard P. Mosekilde L. Charles P. (eds.)
-
Hermann AP., Assessment of calcium intake. A quick method comparerd to a 7 days food diary. In:, Thomsen J, Vestergaard P, Mosekilde L, Charles P, (eds.), 64 (suppl 1) ed., p. 82.
-
Assessment of Calcium Intake. A Quick Method Comparerd to A 7 Days Food Diary
, vol.64
, Issue.SUPPL 1
, pp. 82
-
-
Hermann, A.P.1
-
15
-
-
0029123724
-
Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements
-
Mar
-
Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H,. Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone. 1995 Mar; 16: 385-90.
-
(1995)
Bone.
, vol.16
, pp. 385-390
-
-
Abrahamsen, B.1
Gram, J.2
Hansen, T.B.3
Beck-Nielsen, H.4
-
16
-
-
0034739675
-
Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - Results of the Danish Osteoporosis Prevention Study
-
Oct
-
Mosekilde L, Beck-Nielsen H, Srensen OH, Nielsen SP, Charles P, Vestergaard P, Hermann AP, Gram J, Hansen TB, Abrahamsen B, Ebbesen EN, Stilgren L, Jensen LBr, Brot C, Hansen B, Tofteng CL, Eiken P, Kolthoff N,. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women-results of the Danish Osteoporosis Prevention Study. Maturitas. 2000 Oct; 36: 181-93.
-
(2000)
Maturitas.
, vol.36
, pp. 181-193
-
-
Mosekilde, L.1
Beck-Nielsen, H.2
Srensen, O.H.3
Nielsen, S.P.4
Charles, P.5
Vestergaard, P.6
Hermann, A.P.7
Gram, J.8
Hansen, T.B.9
Abrahamsen, B.10
Ebbesen, E.N.11
Stilgren, L.12
Jensen, L.13
Brot, C.14
Hansen, B.15
Tofteng, C.L.16
Eiken, P.17
Kolthoff, N.18
-
17
-
-
0014887810
-
Tubular reabsorption of calcium in the differential diagnosis of hypercalcaemia. Further experience
-
Dec
-
Transbol I, Hornum I, Hahnemann S, Hasner E, Ohlenschlaeger H, Diemer H, Lockwood K,. Tubular reabsorption of calcium in the differential diagnosis of hypercalcaemia. Further experience. Acta Med Scand. 1970 Dec; 188: 505-22.
-
(1970)
Acta Med Scand.
, vol.188
, pp. 505-522
-
-
Transbol, I.1
Hornum, I.2
Hahnemann, S.3
Hasner, E.4
Ohlenschlaeger, H.5
Diemer, H.6
Lockwood, K.7
-
19
-
-
24144438617
-
3
-
DOI 10.1373/clinchem.2005.052936
-
Maunsell Z, Wright DJ, Rainbow SJ,. Routine Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Measurement of the 25-Hydroxy Metabolites of Vitamins D2 and D3. Clin Chem. 2005 Sept; 51: 1683-90. (Pubitemid 41233104)
-
(2005)
Clinical Chemistry
, vol.51
, Issue.9
, pp. 1683-1690
-
-
Maunsell, Z.1
Wright, D.J.2
Rainbow, S.J.3
-
20
-
-
70449532977
-
High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory
-
Jan
-
Hojskov CS, Heickendorff L, Moller HJ,. High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clinica Chimica Acta. 2010 Jan; 411: 114-6.
-
(2010)
Clinica Chimica Acta.
, vol.411
, pp. 114-116
-
-
Hojskov, C.S.1
Heickendorff, L.2
Moller, H.J.3
-
21
-
-
0028859422
-
Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies
-
Oct
-
Rosenquist C, Qvist P, Bjarnason N, Christiansen C,. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem. 1995 Oct; 41: 1439-45.
-
(1995)
Clin Chem.
, vol.41
, pp. 1439-1445
-
-
Rosenquist, C.1
Qvist, P.2
Bjarnason, N.3
Christiansen, C.4
-
22
-
-
0026676875
-
A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine
-
Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR,. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 1992; 7: 1251-8. (Pubitemid 23000964)
-
(1992)
Journal of Bone and Mineral Research
, vol.7
, Issue.11
, pp. 1251-1258
-
-
Hanson, D.A.1
Weis, M.A.E.2
Bollen, A.-M.3
Maslan, S.L.4
Singer, F.R.5
Eyre, D.R.6
-
23
-
-
70349627819
-
The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion
-
Oct
-
Kantham L, Quinn SJ, Egbuna OI, Baxi K, Butters R, Pang JL, Pollak MR, Goltzman D, Brown EM,. The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion. Am J Physiol Endocrinol Metab. 2009 Oct; 297: E915-23.
-
(2009)
Am J Physiol Endocrinol Metab.
, vol.297
-
-
Kantham, L.1
Quinn, S.J.2
Egbuna, O.I.3
Baxi, K.4
Butters, R.5
Pang, J.L.6
Pollak, M.R.7
Goltzman, D.8
Brown, E.M.9
-
24
-
-
77649147285
-
Physiology and pathophysiology of the calcium-sensing receptor in the kidney
-
Mar
-
Riccardi D, Brown EM,. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol. 2010 Mar; 298: F485-99.
-
(2010)
Am J Physiol Renal Physiol.
, vol.298
-
-
Riccardi, D.1
Brown, E.M.2
-
25
-
-
77951255990
-
Overview of the FGF23-Klotho axis
-
Apr
-
Kuro-o M,. Overview of the FGF23-Klotho axis. Pediatr Nephrol. 2010 Apr; 25: 583-90.
-
(2010)
Pediatr Nephrol.
, vol.25
, pp. 583-590
-
-
Kuro-O, M.1
-
26
-
-
79953272563
-
Phosphate and FGF-23
-
Suppl. Apr;
-
Juppner H,. Phosphate and FGF-23. Kidney Int. Suppl. 2011 Apr; (121): S24-7.
-
(2011)
Kidney Int.
, Issue.121
-
-
Juppner, H.1
-
27
-
-
77951920659
-
Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23
-
Bergwitz C, Juppner H,. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010; 61: 91-104.
-
(2010)
Annu Rev Med.
, vol.61
, pp. 91-104
-
-
Bergwitz, C.1
Juppner, H.2
-
28
-
-
0020076656
-
Parathyroid hormone stimulates mammalian renal 25-Hydroxyvitamin D3-1{alpha}-hydroxylase in vitro
-
KREMER RICH, GOLTZMAN DAVI. Jan
-
KREMER RICH, GOLTZMAN DAVI. Parathyroid hormone stimulates mammalian renal 25-Hydroxyvitamin D3-1{alpha}-hydroxylase in vitro. Endocrinology. 1982 Jan; 110: 294-6.
-
(1982)
Endocrinology.
, vol.110
, pp. 294-296
-
-
-
29
-
-
0033306808
-
3 in intact animals
-
Murayama A, Takeyama Ki, Kitanaka S, Kodera Y, Kawaguchi Y, Hosoya T, Kato S,. Positive and Negative Regulations of the Renal 25-Hydroxyvitamin D3 1α-Hydroxylase Gene by Parathyroid Hormone, Calcitonin, and 1{alpha},25(OH)2D3 in Intact Animals. Endocrinology. 1999 May; 140: 2224-31. (Pubitemid 30636463)
-
(1999)
Endocrinology
, vol.140
, Issue.5
, pp. 2224-2231
-
-
Murayama, A.1
Takeyama, K.-I.2
Kitanaka, S.3
Kodera, Y.4
Kawaguchi, Y.5
Hosoya, T.6
Kato, S.7
-
30
-
-
0031014998
-
Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease
-
DOI 10.1210/jc.82.1.209
-
Davies M, Heys SE, Selby PL, Berry JL, Mawer EB,. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease. J Clin Endocrinol Metab. 1997 Jan; 82: 209-12. (Pubitemid 27021298)
-
(1997)
Journal of Clinical Endocrinology and Metabolism
, vol.82
, Issue.1
, pp. 209-212
-
-
Davies, M.1
Heys, S.E.2
Selby, P.L.3
Berry, J.L.4
Mawer, E.B.5
-
31
-
-
78650909509
-
Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism
-
Jan
-
Rubin MR, Manavalan JS, Dempster DW, Shah J, Cremers S, Kousteni S, Zhou H, McMahon DJ, Kode A, Sliney J, Shane E, Silverberg SJ, Bilezikian JP,. Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism. J Clin Endocrinol Metab. 2011 Jan; 96: 176-86.
-
(2011)
J Clin Endocrinol Metab.
, vol.96
, pp. 176-186
-
-
Rubin, M.R.1
Manavalan, J.S.2
Dempster, D.W.3
Shah, J.4
Cremers, S.5
Kousteni, S.6
Zhou, H.7
McMahon, D.J.8
Kode, A.9
Sliney, J.10
Shane, E.11
Silverberg, S.J.12
Bilezikian, J.P.13
-
32
-
-
0017187051
-
The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts; PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism
-
Sept
-
Parfitt AM,. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts; PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism. Metabolism. 1976 Sept; 25: 1033-69.
-
(1976)
Metabolism.
, vol.25
, pp. 1033-1069
-
-
Parfitt, A.M.1
-
33
-
-
44849121708
-
Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window
-
Mar
-
Bilezikian JP,. Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window. Curr Osteoporos Rep. 2008 Mar; 6: 24-30.
-
(2008)
Curr Osteoporos Rep.
, vol.6
, pp. 24-30
-
-
Bilezikian, J.P.1
-
34
-
-
36148958951
-
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
-
DOI 10.1056/NEJMoa071408
-
Saag KG, Shane E, Boonen S, Marin F, Donley DW, Taylor KA, Dalsky GP, Marcus R,. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007 Nov; 357: 2028-39. (Pubitemid 350106710)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.20
, pp. 2028-2039
-
-
Saag, K.G.1
Shane, E.2
Boonen, S.3
Marin, F.4
Donley, D.W.5
Taylor, K.A.6
Dalsky, G.P.7
Marcus, R.8
-
35
-
-
33947504500
-
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis. A randomized trial
-
Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB,. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med. 2007 Mar; 146: 326-39. (Pubitemid 351650593)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.5
, pp. 326-339
-
-
Greenspan, S.L.1
Bone, H.G.2
Ettinger, M.P.3
Hanley, D.A.4
Lindsay, R.5
Zanchetta, J.R.6
Blosch, C.M.7
Mathisen, A.L.8
Morris, S.A.9
Marriott, T.B.10
-
36
-
-
56649122396
-
Dynamic and structural properties of the skeleton in hypoparathyroidism
-
Dec
-
Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr, Silverberg SJ, Bilezikian JP,. Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res. 2008 Dec; 23: 2018-24.
-
(2008)
J Bone Miner Res.
, vol.23
, pp. 2018-2024
-
-
Rubin, M.R.1
Dempster, D.W.2
Zhou, H.3
Shane, E.4
Nickolas, T.5
Sliney, Jr.J.6
Silverberg, S.J.7
Bilezikian, J.P.8
-
37
-
-
0037961035
-
Increased bone mineral density in patients with chronic hypoparathyroidism
-
DOI 10.1210/jc.2002-021388
-
Chan FK, Tiu SC, Choi KL, Choi CH, Kong AP, Shek CC,. Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab. 2003 July; 88: 3155-9. (Pubitemid 36877488)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.7
, pp. 3155-3159
-
-
Chan, F.K.W.1
Tiu, S.-C.2
Choi, K.-L.3
Choi, C.-H.4
Kong, A.P.S.5
Shek, C.-C.6
-
38
-
-
0029964560
-
Bone histomorphometry in hypoparathyroid patients treated with vitamin D
-
DOI 10.1016/8756-3282(95)00443-2
-
Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P,. Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone. 1996 Feb; 18: 103-8. (Pubitemid 26092589)
-
(1996)
Bone
, vol.18
, Issue.2
, pp. 103-108
-
-
Langdahl, B.L.1
Mortensen, L.2
Vesterby, A.3
Eriksen, E.F.4
Charles, P.5
-
39
-
-
80053217916
-
-
2011 Forsteo product information
-
2011 Forsteo product information.
-
-
-
-
40
-
-
80053199699
-
-
2011 Preotact product information
-
2011 Preotact product information.
-
-
-
-
41
-
-
39049088260
-
Recent updates on the calcium-sensing receptor as a drug target
-
DOI 10.2174/092986708783330601
-
Trivedi R, Mithal A, Chattopadhyay N,. Recent updates on the calcium-sensing receptor as a drug target. Curr Med Chem. 2008; 15: 178-86. (Pubitemid 351234621)
-
(2008)
Current Medicinal Chemistry
, vol.15
, Issue.2
, pp. 178-186
-
-
Trivedi, R.1
Mithal, A.2
Chattopadhyay, N.3
-
42
-
-
77649183744
-
The calcium-sensing receptor in bone cells: A potential therapeutic target in osteoporosis
-
Mar
-
Marie PJ,. The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. Bone. 2010 Mar; 46: 571-6.
-
(2010)
Bone.
, vol.46
, pp. 571-576
-
-
Marie, P.J.1
|